ENTA · Enanta Pharmaceuticals Inc · Share Buybacks
$11.94
-0.24 (-1.97%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2024 earnings call transcript
Market Cap
$354.75M
Shares
29.13M
Volume · Oct 27
319.44K
Avg daily vol (3M)
243.4K
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-07-02 | — | $75,000,000 | — | — | 10-Q , filed 2026-08-12 |
Key facts
CIK
1177648
CUSIP
29251M106
13F (30d)
15 filings
15 filers
Visit website
Investor relations